Tebamide en es it fr

Tebamide Brand names, Tebamide Analogs

Tebamide Brand Names Mixture

  • Alphasel tablets (calcium phosphate [dibasic] + cobalt sulfate + D-alpha tocopheryl acetate + selenium sulfide)
  • Previte (neomycin sulfate + selenium sulfide + streptomycin sulfate + vitamin A + vitamin D + vitamin E + vitamin K1)

Tebamide Chemical_Formula


Tebamide RX_link

No information avaliable

Tebamide fda sheet

Tebamide msds (material safety sheet)

Tebamide MSDS

Tebamide Synthesis Reference

No information avaliable

Tebamide Molecular Weight

280.285 g/mol

Tebamide Melting Point

No information avaliable

Tebamide H2O Solubility

No information avaliable

Tebamide State


Tebamide LogP


Tebamide Dosage Forms

Intravenous (loading dose of 12 to 24 micrograms/kg over 10 minutes followed by a continuous infusion of 0.05 to 0.2 micrograms/kg per minute, adjusted according to response)

Tebamide Indication

For short term treatment of acutely decompensated severe chronic heart failure (CHF).

Tebamide Pharmacology

Levosimendan is a new Ca2+-sensitizing inotropic agent. Ca2+ sensitizers represent a new class of inotropic agents, which overcome the disadvantages associated with currently available inotropic agents in as they are not associated with an increased risk of arrhythmias, cell injury and death due to Ca2+ overload in myocardial cells; they do not increase the activation energy; and they have the potential to reverse contractile dysfunction under pathophysiologic conditions, such as acidosis or myocardial stunning. Levosimendan has not been approved for use in the U.S. or Canada.

Tebamide Absorption

The bioavailability of oral levosimendan is 85 ± 6% in healthy volunteers and 84 ± 4% in patients.

Tebamide side effects and Toxicity

No information avaliable

Tebamide Patient Information

No information avaliable

Tebamide Organisms Affected

Humans and other mammals